Darlene Horton sails into Nile as CMO
This article was originally published in Scrip
Executive Summary
Nile Therapeutics, a biopharmaceutical company that develops novel therapeutics for heart failure patients, has appointed Dr Darlene Horton chief medical officer. Dr Horton was previously CMO of Itero Biopharmaceuticals, and before that, senior vice-president of clinical research at Scios, a Johnson & Johnson company.